Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes

Cell Cycle
Alexey G MittenbergNikolai A Barlev

Abstract

The proteasome is the key player in targeted degradation of cellular proteins and serves as a therapeutic target for treating several blood malignancies. Although in general, degradation of proteins via the proteasome requires their ubiquitination, a subset of proteins can be degraded independently of their ubiquitination by direct interaction with subunits of the 20S proteasome core. Thus, investigation of the proteasome-associated proteins may help identify novel targets of proteasome degradation and provide important insights into the mechanisms of malignant cell proteostasis. Here, using biochemical purification of proteasomes from multiple myeloma (MM) cells followed by mass-spectrometry we have uncovered 77 proteins in total that specifically interacted with the 20S proteasome via its PSMA3 subunit. Our GST pull-down assays followed by western blots validated the interactions identified by mass-spectrometry. Eleven proteins were confirmed to bind PSMA3 only upon apoptotic conditions induced by a combined treatment with the proteasome inhibitor, bortezomib, and genotoxic drug, doxorubicin. Nine of these eleven proteins contained bioinformatically predicted intrinsically disordered regions thus making them susceptible to ub...Continue Reading

References

Aug 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·Y MatsuokaD Pressman
Apr 5, 1996·The Journal of Biological Chemistry·W J MaH Furneaux
May 8, 2002·Nature Reviews. Molecular Cell Biology·Gideon DreyfussNaoyuki Kataoka
Jun 26, 2003·Nucleic Acids Research·Rune LindingToby J Gibson
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Alexey G MittenbergNickolai A Barlev
Jun 12, 2008·International Review of Cell and Molecular Biology·Irina M KonstantinovaAlexey G Mittenberg
Jun 19, 2008·Biochimica Et Biophysica Acta·Isabelle Jariel-EncontreMarc Piechaczyk
Jan 24, 2009·Journal of Molecular Biology·James M BaughEvgeny V Pilipenko
Jun 27, 2009·Cell Death and Differentiation·P TsvetkovY Shaul
Jan 12, 2010·Cell Death and Differentiation·N A BarlevA L Okorokov
Feb 9, 2010·Cell Cycle·Valentina A KulichkovaNickolai A Barlev
Jun 15, 2011·Biochimica Et Biophysica Acta·Jiwon HwangRobert F Kalejta
Jul 20, 2011·Free Radical Biology & Medicine·Tilman GruneKelvin J A Davies
Nov 15, 2011·Biochemical and Biophysical Research Communications·Olga A FedorovaNickolai A Barlev
Jun 26, 2012·Progress in Molecular Biology and Translational Science·Andrew M Pickering, Kelvin J A Davies
Mar 23, 2013·Acta Crystallographica. Section D, Biological Crystallography·Hong WangXu Li
May 21, 2013·Biochimica Et Biophysica Acta·Jenny Erales, Philip Coffino
Aug 3, 2013·Oncotarget·Tatiana N MoiseevaNickolai A Barlev
Nov 5, 2013·Drug Design, Development and Therapy·Shanchun GuoGuangdi Wang
Nov 15, 2013·Nature Communications·Elisa CiliaWim F Vranken
Mar 25, 2014·PloS One·José A González-FelicianoCarlos I González
Apr 5, 2014·Journal of Surgical Oncology·Mitsuro KandaYasuhiro Kodera
Apr 15, 2014·Nucleic Acids Research·Elisa CiliaWim F Vranken
Apr 30, 2014·Chemical Reviews·Robin van der LeeM Madan Babu
Jul 9, 2014·Oncotarget·Anna S TsimokhaNikolai A Barlev
Sep 25, 2014·Biomolecules·Gili Ben-Nissan, Michal Sharon
Dec 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ming GuanBing Su
Mar 11, 2015·Journal of Cellular Physiology·Cheng YuMingwen Fan
Jul 1, 2015·Genetics and Molecular Research : GMR·F S RamosE M S F Ribeiro
Dec 6, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Maxim ShevtsovGabriele Multhoff

❮ Previous
Next ❯

Methods Mentioned

BETA
pull-down
flow cytometry
electrophoresis
ubiquitination

Software Mentioned

DynaMine
MASCOT

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cell Cycle Control & Proteolysis

Key regulators of cell cycle, including cyclins, cyclin dependent kinase inhibitors, DNA replication factors, are controlled by proteolysis. Discover the latest research on cell cycle control and proteolysis.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.